Related Experiment Video
Updated: Apr 30, 2026

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
miRNAs-neutrophil axis: novel insights into acute lung injury and chronic inflammatory lung diseases
Xingning Lai1,2, Jie Zhong1,2, Chenxi Liao1,2
1Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China.
Abstract:
Acute lung injury (ALI) and chronic inflammatory lung disorders constitute significant clinical burdens with high morbidity and mortality. Neutrophils are commonly found in lung diseases and serve as pivotal effector cells governing pulmonary inflammation. MicroRNAs (miRNAs) have emerged as critical regulators of neutrophil biology and inflammatory responses. This review summarizes current understanding of miRNA-mediated regulation of neutrophil dynamics, including granulopoiesis, recruitment, and neutrophil extracellular trap (NET) formation, and delineates the contributions of the miRNA-neutrophil axis to the pathogenesis of ALI, asthma, pulmonary fibrosis, and lung cancer. This review describes the dual roles of miRNAs, acting either as promoters or suppressors in neutrophil biology and inflammatory lung diseases, and highlights mechanistic insights into miRNA-mediated pathways influencing neutrophil-driven inflammation and tissue injury. Furthermore, we explore the therapy potential of targeting the miRNA-neutrophil axis, evaluating miRNA-based therapeutics as novel strategies to modulate neutrophil-driven pathology in lung diseases. By elucidating the miRNAs-neutrophil axis as an integrative conceptual framework, this review aims to spotlight promising avenues for developing therapies for debilitating acute and chronic respiratory disorders.
Insights
MicroRNAs (miRNAs) regulate neutrophils, key cells in lung inflammation and diseases like acute lung injury (ALI). Targeting this miRNA-neutrophil axis offers new therapeutic strategies for respiratory disorders.
Area of Science:
- Pulmonary Medicine
- Molecular Biology
- Immunology
Background:
- Acute lung injury (ALI) and chronic lung diseases pose significant health challenges.
- Neutrophils are central to lung inflammation and disease pathogenesis.
- MicroRNAs (miRNAs) are emerging as key regulators of neutrophil function.
Purpose of the Study:
- To review miRNA-mediated regulation of neutrophil dynamics.
- To delineate the role of the miRNA-neutrophil axis in lung diseases.
- To explore therapeutic potential of targeting this axis.
Main Methods:
- Literature review of miRNA regulation in neutrophil biology.
- Analysis of miRNA's role in granulopoiesis, recruitment, and NET formation.
- Examination of miRNA-neutrophil axis in ALI, asthma, fibrosis, and lung cancer.
Main Results:
- miRNAs exhibit dual roles, promoting or suppressing neutrophil activity.
- Mechanistic insights into miRNA pathways influencing neutrophil-driven inflammation.
- The miRNA-neutrophil axis significantly contributes to lung tissue injury.
Conclusions:
- The miRNA-neutrophil axis is a critical framework for understanding lung inflammation.
- Targeting miRNAs presents novel therapeutic avenues for respiratory diseases.
- miRNA-based therapeutics may modulate neutrophil-driven pathology effectively.
Related Concept Videos
Acute Inflammation I: Cellular Phase
Chronic Inflammation: Introduction
Acute Inflammation I: Inflammatory Response
Inflammation
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Microbiota of the Respiratory Tract

